JP2021529527A5 - - Google Patents

Info

Publication number
JP2021529527A5
JP2021529527A5 JP2020573229A JP2020573229A JP2021529527A5 JP 2021529527 A5 JP2021529527 A5 JP 2021529527A5 JP 2020573229 A JP2020573229 A JP 2020573229A JP 2020573229 A JP2020573229 A JP 2020573229A JP 2021529527 A5 JP2021529527 A5 JP 2021529527A5
Authority
JP
Japan
Prior art keywords
medium
concentrated
cells
batch
culture
Prior art date
Application number
JP2020573229A
Other languages
English (en)
Japanese (ja)
Other versions
JP7419273B2 (ja
JPWO2020010080A5 (https=
JP2021529527A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/040298 external-priority patent/WO2020010080A1/en
Publication of JP2021529527A publication Critical patent/JP2021529527A/ja
Publication of JPWO2020010080A5 publication Critical patent/JPWO2020010080A5/ja
Publication of JP2021529527A5 publication Critical patent/JP2021529527A5/ja
Priority to JP2024001657A priority Critical patent/JP2024050590A/ja
Application granted granted Critical
Publication of JP7419273B2 publication Critical patent/JP7419273B2/ja
Priority to JP2025247705A priority patent/JP2026048825A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020573229A 2018-07-03 2019-07-02 組換えタンパク質を製造する方法 Active JP7419273B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2024001657A JP2024050590A (ja) 2018-07-03 2024-01-10 組換えタンパク質を製造する方法
JP2025247705A JP2026048825A (ja) 2018-07-03 2025-12-12 組換えタンパク質を製造する方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862693606P 2018-07-03 2018-07-03
US62/693,606 2018-07-03
PCT/US2019/040298 WO2020010080A1 (en) 2018-07-03 2019-07-02 Methods of producing recombinant proteins

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024001657A Division JP2024050590A (ja) 2018-07-03 2024-01-10 組換えタンパク質を製造する方法

Publications (4)

Publication Number Publication Date
JP2021529527A JP2021529527A (ja) 2021-11-04
JPWO2020010080A5 JPWO2020010080A5 (https=) 2022-07-08
JP2021529527A5 true JP2021529527A5 (https=) 2022-07-08
JP7419273B2 JP7419273B2 (ja) 2024-01-22

Family

ID=67470657

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020573229A Active JP7419273B2 (ja) 2018-07-03 2019-07-02 組換えタンパク質を製造する方法
JP2024001657A Pending JP2024050590A (ja) 2018-07-03 2024-01-10 組換えタンパク質を製造する方法
JP2025247705A Pending JP2026048825A (ja) 2018-07-03 2025-12-12 組換えタンパク質を製造する方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2024001657A Pending JP2024050590A (ja) 2018-07-03 2024-01-10 組換えタンパク質を製造する方法
JP2025247705A Pending JP2026048825A (ja) 2018-07-03 2025-12-12 組換えタンパク質を製造する方法

Country Status (23)

Country Link
US (2) US20210253996A1 (https=)
EP (2) EP3818078B1 (https=)
JP (3) JP7419273B2 (https=)
KR (2) KR20250153311A (https=)
CN (1) CN112839954A (https=)
AU (1) AU2019299358B2 (https=)
CA (1) CA3104684A1 (https=)
DK (1) DK3818078T3 (https=)
EA (1) EA202092904A1 (https=)
ES (1) ES2976708T3 (https=)
FI (1) FI3818078T3 (https=)
HR (1) HRP20240584T1 (https=)
HU (1) HUE066560T2 (https=)
IL (2) IL324666A (https=)
LT (1) LT3818078T (https=)
MX (1) MX2020013633A (https=)
PL (1) PL3818078T3 (https=)
PT (1) PT3818078T (https=)
RS (1) RS65472B1 (https=)
SG (1) SG11202012582QA (https=)
SI (1) SI3818078T1 (https=)
SM (1) SMT202400173T1 (https=)
WO (1) WO2020010080A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK181991B1 (en) * 2021-11-11 2025-05-15 Dsm Ip Assets Bv Combined fermentation process for producing one or more human milk oligosaccharide(s) (hmo(s)) in escherichia coli
JP2025520392A (ja) * 2022-06-15 2025-07-03 ユーシービー バイオファルマ エスアールエル 細胞培養プロセス
EP4339274B1 (en) 2022-09-13 2025-03-26 Sartorius Stedim Biotech GmbH Method for operating a bioprocess installation for production of a bioproduct
KR20240172522A (ko) * 2023-06-01 2024-12-10 (주)알테오젠 지속형 호르몬 수용체 길항제의 생산 방법

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4515893A (en) 1979-04-26 1985-05-07 Ortho Pharmaceutical Corporation Hybrid cell line for producing complement-fixing monoclonal antibody to human T cells
US5672347A (en) 1984-07-05 1997-09-30 Genentech, Inc. Tumor necrosis factor antagonists and their use
IL85035A0 (en) 1987-01-08 1988-06-30 Int Genetic Eng Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
US5091313A (en) 1988-08-05 1992-02-25 Tanox Biosystems, Inc. Antigenic epitopes of IgE present on B cell but not basophil surface
US5720937A (en) 1988-01-12 1998-02-24 Genentech, Inc. In vivo tumor detection assay
EP0420937B1 (en) 1988-06-21 1994-11-09 Genentech, Inc. Therapeutic compositions for the treatment of myocardial infarction
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
CA2113813C (en) 1991-08-14 2005-04-12 Paula M. Jardieu Immunoglobulin variants for specific fc epsilon receptors
WO1994004188A1 (en) 1992-08-21 1994-03-03 Genentech, Inc. Method for treating an lfa-1-mediated disorder
US5736137A (en) 1992-11-13 1998-04-07 Idec Pharmaceuticals Corporation Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
DK0733207T3 (da) 1993-12-10 1998-04-20 Genentech Inc Fremgangsmåder til diagnose af allergi og screening af anti-allergi-terapeutika
DK0739214T3 (da) 1994-01-18 1998-10-07 Genentech Inc Fremgangsmåde til behandling af parasitinfektionerunder anvendelse af IgE antagonister
US5702946A (en) 1994-03-03 1997-12-30 Genentech, Inc. Anti-IL-8 monoclonal antibodies for treatment of inflammatory disorders
IL117645A (en) 1995-03-30 2005-08-31 Genentech Inc Vascular endothelial cell growth factor antagonists for use as medicaments in the treatment of age-related macular degeneration
AU6267896A (en) 1995-06-07 1996-12-30 Imclone Systems Incorporated Antibody and antibody fragments for inhibiting the growth oftumors
IL125255A (en) 1996-01-23 2002-02-10 Genentech Inc Anti-cd18 antibodies for treating stroke
US7147851B1 (en) 1996-08-15 2006-12-12 Millennium Pharmaceuticals, Inc. Humanized immunoglobulin reactive with α4β7 integrin
WO1998023761A1 (en) 1996-11-27 1998-06-04 Genentech, Inc. HUMANIZED ANTI-CD11a ANTIBODIES
JP3957765B2 (ja) 1997-04-07 2007-08-15 ジェネンテク・インコーポレイテッド 抗vegf抗体
EP0981618B2 (en) 1997-05-15 2011-08-24 Genentech, Inc. Anti-apo-2 antibody
US6946129B1 (en) 1999-06-08 2005-09-20 Seattle Genetics, Inc. Recombinant anti-CD40 antibody and uses thereof
AU778199B2 (en) 1999-10-29 2004-11-25 Genentech Inc. Anti-prostate stem cell antigen (PSCA) antibody compositions and methods of use
TWI374935B (en) * 2004-08-27 2012-10-21 Pfizer Ireland Pharmaceuticals Production of α-abeta
TWI456062B (zh) * 2006-09-13 2014-10-11 Abbvie Inc 細胞培養改良
EP2673296B1 (en) 2011-02-07 2018-10-24 Cerenis Therapeutics Holding SA Lipoprotein complexes and manufacturing and uses thereof
DK2726600T3 (en) * 2011-07-01 2017-05-15 Amgen Inc Mammalian Cell Culture
DK3083933T3 (da) * 2013-12-20 2026-03-16 Biogen Ma Inc Anvendelse af perfusionssåningskulturer til forbedring af biofarmaceutisk fed-batch-produktionskapacitet og -produktkvalitet
JP2017516484A (ja) * 2014-06-03 2017-06-22 ルピン・リミテッド タンパク質生産のための細胞培養工程
PT3152317T (pt) * 2014-06-04 2019-04-18 Amgen Inc Métodos de colheita de culturas de células de mamíferos
WO2015198451A1 (ja) 2014-06-26 2015-12-30 楽天株式会社 情報処理装置、情報処理方法及び情報処理プログラム

Similar Documents

Publication Publication Date Title
JP2021529527A5 (https=)
CN118086167B (zh) 一种生产l-色氨酸的基因工程菌及其构建方法与应用
RU2009138226A (ru) Способы производства белка с использованием соединений, препятствующих старению
CN105441497B (zh) 一种利用微生物发酵和微生物转化偶联生产尸胺的方法
CN108795789A (zh) 一种高产衣康酸解脂耶氏酵母工程菌株及其构建方法、发酵工艺与应用
Meng et al. Enhancement of heterologous protein production in Corynebacterium glutamicum via atmospheric and room temperature plasma mutagenesis and high-throughput screening
FI3818078T3 (fi) Menetelmiä rekombinanttiproteiinien tuottamiseksi
JP7680418B2 (ja) 高密度連続接種の細胞培養方法及びその応用
CN118879517B (zh) 解脂耶罗维亚酵母Yl590及其应用
CN103865869B (zh) 一株产α-酮基丁酸的基因工程菌及其应用
CN117050163A (zh) 一种分泌表达重组iii型胶原蛋白的毕赤酵母工程菌及其应用
CN118956632A (zh) 高产2′-岩藻糖基乳糖的重组解脂耶氏酵母菌及其构建方法与应用
CN107287144B (zh) 一种代谢改造的枯草芽孢杆菌生物转化细胞及其制备方法与应用
CN117736948A (zh) 一种高产l-丙氨酸的大肠杆菌重组菌构建方法及应用
JPWO2020010080A5 (https=)
CN116814519B (zh) 一种利用蔗糖生产肌醇的大肠杆菌工程菌株、及其构建方法和应用
CN120173986A (zh) 一种用于黏着剑菌的ed途径调控基因在维生素b12工业生产的应用
CN118931932A (zh) 一种产生l-缬氨酸的大肠杆菌及其应用
CN119161416B (zh) 一种高效合成四氢嘧啶的基因工程菌及其构建方法
CN116254286B (zh) 氰胺诱导的酿酒酵母工程菌及其构建方法
JPWO2023200008A5 (https=)
CN114317535B (zh) 基因缺失cho细胞系及其制备方法及应用
AR129619A1 (es) Métodos de producción de proteínas recombinantes en un biorreactor y/o de aumento del rendimiento del cultivo celular mediante estrategia de alimentación específica
ES2688044T3 (es) Uso de una cepa procariota con supresión de auxotrofias para aminoácidos para la producción recombinante de un polipéptido
JP2024163267A5 (https=)